This study looks at how well stem cells from umbilical cord blood work when used to treat patients with serious blood diseases or immune disorders. Researchers want to see how quickly these cells help the body produce new blood and monitor for common side effects like graft versus host disease, where the new cells react against the patient's body.
This trial is for patients with conditions like leukemia, lymphoma, or certain immune and metabolic disorders who need a stem cell transplant. You may be eligible if you do not have a closely matched donor available and meet the specific health requirements set by the study team.
Participants will receive a cord blood transplant after undergoing treatments like chemotherapy and radiation to prepare their body. Doctors will then closely watch your recovery to see how well the new cells grow and manage any reactions that may occur during the process.
The study is currently recruiting patients and is taking place in Rochester, New York. If you are interested, your medical team can help you determine if this location is right for you.
- 1Tests the effectiveness of using umbilical cord blood as an alternative to traditional stem cell donors.
- 2Carefully tracks how quickly the body recovers its blood cell counts after the transplant.
- 3Monitors for potential complications, such as the body's immune reaction to the new donor cells.
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.